Canada–EU trade agreement expected to increase drug costs

Canada-EU trade agreement expected to increase drug costs.

Brand-name drug costs expected to rise under CETA.

New brand-name pharmaceuticals are projected to cost roughly 6.2% more in the long run, at an estimated cost of $850 million a year for Canadians, if the proposed Canada–European Union Comprehensive Economic and Trade Agreement (CETA) comes into effect. CETA has been signed, but awaits ratification by Canadian and European Parliaments. Bill C-30 had second reading in Canada’s Parliament Nov. 21...

Proposed trade agreement could increase patent protection for pharmaceuticals.

Patients' willingness to discuss trade-offs to lower their out-of-pocket drug costs.

reducing sodium intake and increasing potassium intake. There are various ways to improve intakes of minerals in the population. Adherence to dietary guidelines, with ample fruit and vegetables, whole grains, and lowfat dairy products, should be promoted. Food companies can help by promoting the availability of healthier foods and also by improving the type and content of minerals in their prod...

The Role of Preferential Trade Agreement (PTA) between Iran and Malaysia their Intra industry Trade (IIT)